References
- Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274 - 93; http://dx.doi.org/10.1016/j.cell.2012.03.017; PMID: 22500797
- Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012; 148:1172 - 87; http://dx.doi.org/10.1016/j.cell.2012.02.005; PMID: 22424228
- Rukov JL, Shomron N. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 2011; 17:412 - 23; http://dx.doi.org/10.1016/j.molmed.2011.04.003; PMID: 21652264
- Totary-Jain H, Sanoudou D, Dautriche CN, Schneller H, Zambrana L, Marks AR. Rapamycin resistance is linked to defective regulation of Skp2. Cancer Res 2012; 72:1836 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-11-2195; PMID: 22311674
- Luo Y, Marx SO, Kiyokawa H, Koff A, Massagué J, Marks AR. Rapamycin resistance tied to defective regulation of p27Kip1. Mol Cell Biol 1996; 16:6744 - 51; PMID: 8943329
- Totary-Jain H, Sanoudou D, Ben-Dov IZ, Dautriche CN, Guarnieri P, Marx SO, et al. Reprogramming of the microRNA transcriptome mediates resistance to rapamycin. J Biol Chem 2013; http://dx.doi.org/10.1074/jbc.M112.416446; PMID: 23300087
- Bui TV, Mendell JT. Myc: Maestro of MicroRNAs. Genes Cancer 2010; 1:568 - 75; http://dx.doi.org/10.1177/1947601910377491; PMID: 20882107